Why and by How Much is Insulin Absorption Reduced by Insulin-derived Amyloidosis? A Scoping Review.

Ibuki, Ai; Fukuda, Mayu; Akase, Tomoko; Sugama, Junko; Yanagita, Toshihiko

Ibuki, Ai; Fukuda, Mayu; Akase, Tomoko; Sugama, Junko; Yanagita, Toshihiko.

Afiliação

Ibuki A; Department of Adult Health Nursing, Faculty of Nursing, Kyoritsu Women's University.
Fukuda M; Department of Biological Science and Nursing, School of Medicine, Yokohama City University.
Akase T; Department of Biological Science and Nursing, School of Medicine, Yokohama City University.
Sugama J; Research Center for Implementation Nursing Science Initiative, Innovation Promotion Division, Research Promotion Headquarters, Fujita Health University.
Yanagita T; Department of Clinical Pharmacology, School of Nursing, Faculty of Medicine, University of Miyazaki.

Yakugaku Zasshi ; 143(10): 865-870, 2023.

Article em En | MEDLINE | ID: mdl-37779016

Assuntos

Amiloidose; Diabetes Mellitus; Humanos; Insulina; Diabetes Mellitus/tratamento farmacológico; Amiloidose/tratamento farmacológico; Amiloidose/induzido quimicamente; Pele; Injeções Subcutâneas

Palavras-chave

diabetes mellitus; insulin absorption; insulin subcutaneous injection; insulin-derived amyloidosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Amiloidose Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Amiloidose Idioma: En Ano de publicação: 2023 Tipo de documento: Article